Trump’s "Shock and Awe" Agenda: Executive Orders from Day One 
Goldman Predicts 50% Odds of 10% U.S. Tariff on Copper by Q1 Close 
Urban studies: Doing research when every city is different 
Geopolitical Shocks That Could Reshape Financial Markets in 2025 
U.S. Treasury Yields Expected to Decline Amid Cooling Economic Pressures 
China's Refining Industry Faces Major Shakeup Amid Challenges 
S&P 500 Relies on Tech for Growth in Q4 2024, Says Barclays 
US Gas Market Poised for Supercycle: Bernstein Analysts 
FxWirePro: USD/CAD extends advance as stronger dollar and falling oil weighs on loonie 
FxWirePro-24-Hour Crypto Category-Based Performance Dashboard 
FxWirePro: GBP/USD slips as dollar extends gains after US PMI data 
Indonesia Surprises Markets with Interest Rate Cut Amid Currency Pressure 
China’s Growth Faces Structural Challenges Amid Doubts Over Data 
Oil Prices Dip Slightly Amid Focus on Russian Sanctions and U.S. Inflation Data 
FxWirePro: EUR/AUD downside pressure builds, key support level in focus 
FxWirePro: USD/ZAR rises as dollar gains on Fed hike bets 
Stock Futures Dip as Investors Await Key Payrolls Data 
Add as a preferred source on Google
NZD/USD chart - Trading View
NZD/USD trades comatose around 21-EMA resistance, technical bias still supports upside.
The major was trading 0.26% lower at 0.6024 at around 04:00 GMT, with session highs at 0.6063 and lows at 0.5992.
Market’s risk-tone remains under pressure. PBoC's rate cut and the liquidity injection have failed to put a bid under the risk assets.
US dollar is drawing safe-haven bids, while the Kiwi under pressure after RBNZ indicated readiness to take further measures to combat the COVID-19 pandemic.
The Reserve Bank Of New Zealand (RBNZ) said the central bank has other tools on hand to keep cost of borrowing low for as long as needed.
NZD/USD has paused 6-day winning streak. But, technical indicators still support upside. Major trend is bearish, but break above 21-EMA could see more upside momentum.
'Death Cross' (bearish 50-DMA crossover on 200-DMA) to limit upside. Rejection at 21-EMA will see downside resumption.
No major data/events scheduled for the day. Focus remains on the virus/stimulus news for direction.
Major Support Levels - 0.5960 (38.2% Fib), 0.5938 (5-DMA)
Major Resistance Levels - 0.6025 (21-EMA), 0.6112 (50% Fib)
